This CDC Funding Opportunity Announcement (FOA), supported by funds available to CDC under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, invites cooperative agreement (U48) applications from Health Promotion and Disease Prevention Research Centers
(PRCs) to perform comparative effectiveness research (CER) that compares innovative public health strategies or interventions, in new settings or populations (such as minorities or people with disabilities), preferably includes CER that assesses the impact of policy and environmental interventions, and includes new endpoints such as biologic measures or combined clinical and social interventions.
It should be noted, however, that if biologic measures are included, then related, validated, or generally accepted health outcomes should also be included as part of the same research proposal.
Obtain Full Opportunity Text:
The link to the full announcement is located at the top of this page.Additional Information of Eligibility:
The following organizations/institutions are eligible to apply.
Consistent with the purposes of the Recovery Act (in particular, to preserve and create jobs and promote economic recovery in the United States, and to provide investments needed to increase economic efficiency by spurring technological advances in science and health), applicants must be a domestic (United States) institution/organization of one of the types listed below.
The United States institution/organization must be located in the 50 states, or in the territories and possessions of the U.S., Commonwealth of Puerto Rico, Trust Territory of the Pacific Islands, or District of Columbia.
Foreign organizations/institutions are not permitted as the applicant organization.
The HHS ARRA Spend Plan for this CDC program limits eligibility only to applicants who have applied for and have been selected as Prevention Research Centers under CDC Program Announcement DP-09-001.
Competition is limited to PRCs under this CDC Program Announcement because (1) they are uniquely positioned to perform, oversee, and coordinate public health-oriented CER that promotes the field of prevention research due to their established relationships with community partners and previous experience with CER and (2) these PRCs recently competed for prevention research funding and were deemed to be the best applicants among research institutions that include all schools of public health and schools of medicine with preventive medicine residency programs.
The 37 currently funded PRCs at the following institutions are eligible to apply for this FOA: 1.
Boston University 2.
Case Western Reserve University 3.
Columbia University 4.
Dartmouth College 5.
Emory University 6.
Harvard University 7.
Johns Hopkins University 8.
Morehouse School of Medicine 9.
New York University School of Medicine 10.
Ohio State University 11.
Oregon Health and Science University 12.
Saint Louis University (with Washington University) 13.
San Diego State University (with University of California at San Diego) 14.
Texas A&M Health Science Center 15.
Tulane University 16.
University of Alabama at Birmingham 17.
University of Arizona 18.
University of Arkansas for Medical Sciences 19.
University of California at Berkeley 20.
University of California at Los Angeles 21.
University of Colorado Denver 22.
University of Kentucky 23.
University of Maryland 24.
University of Massachusetts Medical School 25.
University of MichigFull Opportunity Web Address:Contact:
CDC Procurement and Grants Technical Information Management SectionPhone 770-488-2700 Agency Email Description:
Technical Information Management Section Agency Email:
email@example.com Date Posted:
2010-02-25Application Due Date: